Impact of CD34+ Graft Cell Dose on Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-198392
Abstract: Background: CD34+ graft cell dose is imperative to outcomes after allogeneic peripheral blood stem cell transplantation (allo-PBSCT). A few studies have evaluated the effect of graft cell dose on outcomes after allo-PBSCT; however, the data… read more here.
Keywords: cell dose; million cd34; graft cell; cell ... See more keywords